Back to Search
DANIELLE HURST, MD
MD
Surgery Physician
NPI: 1356034409Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
4351051704(MI)
Research & Publications (20)
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
PMID 18841483·Clin Exp Metastasis·2009
7-preclinical
Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
PMID 19190326·Cancer Res·2009
8-other
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
PMID 18211900·J Biol Chem·2008
7-preclinical
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.
PMID 17004712·J Med Chem·2006
7-preclinical
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.
PMID 16919237·Biochem Biophys Res Commun·2006
7-preclinical
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
PMID 16026329·Biochem J·2005
8-other
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
PMID 14533979·Biochem J·2004
8-other
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor.
PMID 12435794·Mol Pharmacol·2002
8-other
Diagnosis and endovascular treatment of iliocaval compression syndrome.
PMID 11436082·J Vasc Surg·2001
8-other
Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer.
PMID 11178975·Biochem Biophys Res Commun·2001
8-other
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
PMID 19332369·Bioorg Med Chem Lett·2009
7-preclinical
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
PMID 19212637·Oncol Rep·2009
7-preclinical
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
PMID 19308666·Clin Exp Metastasis·2009
8-other
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
PMID 19036582·Bioorg Med Chem Lett·2009
7-preclinical
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
PMID 19070953·Cancer Lett·2009
7-preclinical
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
PMID 19585508·Int J Cancer·2009
8-other
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
PMID 18511157·Eur J Med Chem·2009
8-other
Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.
PMID 19047132·Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2601 W. THIRTEEN MILE RD, BEAUMONT-ROYAL OAK
ROYAL OAK, MI 48073 - Phone
- (248) 898-5000
Quick Facts
- NPI
- 1356034409
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile